Impact on delirium of the use of DEXmedetomidine as first-line sedation in PEDIAtric intensive care: research hub

Impact on delirium of the use of DEXmedetomidine as first-line sedation in PEDIAtric intensive care: the PEDIADEX randomized controlled trial

This study looks at how a medicine called dexmedetomidine, given first for sleep in the intensive care unit (ICU), affects confusion (delirium) in children. It compares it to another common medicine, midazolam. The main goal is to see if fewer children get confused when given dexmedetomidine.